COLL vs PTC · P/E 17, rev $181.9M vs P/E 48, rev $2.74B
Collegium Pharmaceutical Inc (COLL) versus PTC Inc (PTC) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
PTC Inc (PTC) is a software - application company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported PTC revenue for 2025-09-30 was $2.74B. Net income was $734.0M. Revenue was up 19.2% from 2024-09-30 to 2025-09-30. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
Not investment advice. Open the COLL and PTC stock pages for the full models.
Not investment advice.